HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dario A Paggiarino Selected Research

PF-04523655

11/2012Dose-ranging evaluation of intravitreal siRNA PF-04523655 for diabetic macular edema (the DEGAS study).
9/2012Evaluation of the siRNA PF-04523655 versus ranibizumab for the treatment of neovascular age-related macular degeneration (MONET Study).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dario A Paggiarino Research Topics

Disease

1Cataract (Cataracts)
01/2019
1Inflammation (Inflammations)
01/2019
1Uveitis
01/2019
1Posterior Uveitis
01/2019
1Renal Cell Carcinoma (Grawitz Tumor)
02/2017
1Macular Edema
11/2012
1Macular Degeneration (Age-Related Maculopathy)
09/2012
1Choroidal Neovascularization
09/2012

Drug/Important Bio-Agent (IBA)

2PF-04523655IBA
11/2012 - 09/2012
2Small Interfering RNA (siRNA)IBA
11/2012 - 09/2012
1Fluocinolone Acetonide (Capex)FDA LinkGeneric
01/2019
1SteroidsIBA
01/2019
1salicylhydroxamic acid (SHAM)IBA
01/2019
1sonepcizumabIBA
02/2017
1sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
02/2017
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2017
1Ranibizumab (Lucentis)FDA Link
09/2012

Therapy/Procedure

2Therapeutics
02/2017 - 09/2012
1Injections
01/2019
1Light Coagulation
11/2012
1Lasers (Laser)
11/2012